Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan M Domchek

Showing results (51-60 of 361) with videos related to

Pageof 37
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|April 4, 2023
Nationwide Trends and Determinants of Germline BRCA1/2 Testing in Patients With Breast and Ovarian CancerKelsey S Lau-Min, Anne Marie McCarthy, Katherine L Nathanson, et al.
Cancer Epidemiology|July 2, 2013
Agreement of self-reported hormone receptor status with cancer registry data in young breast cancer patientsAnne Marie McCarthy, Erin McGuire, Mirar Bristol, et al.
AJR. American Journal of Roentgenology|February 26, 2015
Breast MRI fibroglandular volume and parenchymal enhancement in BRCA1 and BRCA2 mutation carriers before and immediately after risk-reducing salpingo-oophorectomyMichael J DeLeo, Susan M Domchek, Despina Kontos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2003
Application of breast cancer risk prediction models in clinical practiceSusan M Domchek, Andrea Eisen, Kathleen Calzone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2012
How genetic variant libraries effectively extend gene testing patents: implications for intellectual property and good clinical careSean McElligott, Robert I Field, Mirar Bristol-Demeter, et al.
JCO Precision Oncology|February 9, 2022
Retrospective Survival Analysis of Patients With Advanced Pancreatic Ductal Adenocarcinoma and Germline <i>BRCA</i> or <i>PALB2</i> MutationsKim A Reiss, Shun Yu, Renae Judy, et al.
Cancer|January 30, 2002
Lymphomas of the breast: primary and secondary involvementSusan M Domchek, Jonathan L Hecht, Mark D Fleming, et al.
Genetic Testing|April 29, 2005
Knowledge, attitudes, and utilization of BRCA1/2 testing among women with early-onset breast cancerNikki Peters, Susan M Domchek, Susan M Domcheck, et al.
Cancer Biology & Therapy|August 26, 2006
Childhood cancer in families with and without BRCA1 or BRCA2 mutations ascertained at a high-risk breast cancer clinicGabriel A Brooks, Jill E Stopfer, Julie Erlichman, et al.
Cancer Biology & Therapy|December 19, 2007
Differential lysis of tumors by polyclonal T cell lines and T cell clones specific for hTERTDih-Yih Chen, Barbara A Vance, Lara B S Thompson, et al.
Pageof 37

Showing results (51-60 of 361) with videos related to

Sort By:
Pageof 37
Journal of the National Comprehensive Cancer Network : JNCCN|April 4, 2023
Nationwide Trends and Determinants of Germline BRCA1/2 Testing in Patients With Breast and Ovarian CancerKelsey S Lau-Min, Anne Marie McCarthy, Katherine L Nathanson, et al.
Cancer Epidemiology|July 2, 2013
Agreement of self-reported hormone receptor status with cancer registry data in young breast cancer patientsAnne Marie McCarthy, Erin McGuire, Mirar Bristol, et al.
AJR. American Journal of Roentgenology|February 26, 2015
Breast MRI fibroglandular volume and parenchymal enhancement in BRCA1 and BRCA2 mutation carriers before and immediately after risk-reducing salpingo-oophorectomyMichael J DeLeo, Susan M Domchek, Despina Kontos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2003
Application of breast cancer risk prediction models in clinical practiceSusan M Domchek, Andrea Eisen, Kathleen Calzone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2012
How genetic variant libraries effectively extend gene testing patents: implications for intellectual property and good clinical careSean McElligott, Robert I Field, Mirar Bristol-Demeter, et al.
JCO Precision Oncology|February 9, 2022
Retrospective Survival Analysis of Patients With Advanced Pancreatic Ductal Adenocarcinoma and Germline <i>BRCA</i> or <i>PALB2</i> MutationsKim A Reiss, Shun Yu, Renae Judy, et al.
Cancer|January 30, 2002
Lymphomas of the breast: primary and secondary involvementSusan M Domchek, Jonathan L Hecht, Mark D Fleming, et al.
Genetic Testing|April 29, 2005
Knowledge, attitudes, and utilization of BRCA1/2 testing among women with early-onset breast cancerNikki Peters, Susan M Domchek, Susan M Domcheck, et al.
Cancer Biology & Therapy|August 26, 2006
Childhood cancer in families with and without BRCA1 or BRCA2 mutations ascertained at a high-risk breast cancer clinicGabriel A Brooks, Jill E Stopfer, Julie Erlichman, et al.
Cancer Biology & Therapy|December 19, 2007
Differential lysis of tumors by polyclonal T cell lines and T cell clones specific for hTERTDih-Yih Chen, Barbara A Vance, Lara B S Thompson, et al.
Pageof 37